Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ophthalmic Artery Blood Flow in Glaucoma
NCT02656979Unknown
- Sponsor
- Umeå University
- Start
- Dec 2013
- Primary completion
- Sep 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of latanoprost in Glaucoma and ocular hypertension (2 arms), sponsored by Umeå University. Primary endpoint: Blood flow of the ophthalmic artery up to 4 years. Status: unknown.
02
Drugs
latanoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT02656979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656979.